Carregant...
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis
Background: Dalfampridine extended release (ER) improves walking in people with multiple sclerosis (MS), as demonstrated by walking speed improvement. This exploratory study evaluated treatment effects of dalfampridine-ER on gait, balance, and walking through treatment withdrawal and reinitiation. M...
Guardat en:
| Publicat a: | Int J MS Care |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Consortium of Multiple Sclerosis Centers
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673920/ https://ncbi.nlm.nih.gov/pubmed/26664333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2014-036 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|